olmesartan has been researched along with fimasartan in 1 studies
| Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (fimasartan) | Trials (fimasartan) | Recent Studies (post-2010) (fimasartan) |
|---|---|---|---|---|---|
| 841 | 185 | 554 | 91 | 42 | 89 |
| Protein | Taxonomy | olmesartan (IC50) | fimasartan (IC50) |
|---|---|---|---|
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0045 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, K; Chung, WB; Her, SH; Ihm, SH; Jang, SW; Jeon, DS; Lee, JM; Park, CS; Seung, KB; Yoo, KD | 1 |
1 trial(s) available for olmesartan and fimasartan
| Article | Year |
|---|---|
Effect of Fimasartan versus Valsartan and Olmesartan on Office and Ambulatory Blood Pressure in Korean Patients with Mild-to-Moderate Essential Hypertension: A Randomized, Double-Blind, Active Control, Three-Parallel Group, Forced Titration, Multicenter,
Topics: Adult; Aged; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Double-Blind Method; Essential Hypertension; Female; Humans; Imidazoles; Male; Middle Aged; Pyrimidines; Republic of Korea; Tetrazoles; Valsartan; Young Adult | 2020 |